Compound Evidence File
#EC-2026-0242
TrenMix 200
Filed under Injectable Oils. The bureau holds 127 laboratory returns for this compound from 41 distinct subjects. Scores below are per-subject aggregates; open a subject row for the underlying evidence.
Cross-Index
Subjects Shipping This Compound
41 SUBJECTS| Subject | Grade | Samples | Mean | Min | Max | First seen | Last seen |
|---|---|---|---|---|---|---|---|
| Tianjin Finder Chemical TFCCASE #VI-2026-0693 | A | 7 | 10.0 | 9.9 | 10.0 | 14 Nov 2025 | 16 Apr 2026 |
| WuXi TIDESCASE #VI-2026-0335 | A | 5 | 10.0 | 10.0 | 10.0 | 19 Apr 2026 | 11 Jul 2026 |
| BachemCASE #VI-2026-0314 | A | 4 | 10.0 | 9.9 | 10.0 | 2 Dec 2025 | 28 May 2026 |
| Mokemei BiotechnologyCASE #VI-2026-0540 | A | 4 | 10.0 | 10.0 | 10.0 | 23 Feb 2026 | 9 Jun 2026 |
| Thermo Fisher ScientificCASE #VI-2026-0142 | A | 4 | 10.0 | 9.9 | 10.0 | 25 Dec 2025 | 15 Aug 2026 |
| QYAOBIOCASE #VI-2026-0861 | A | 3 | 10.0 | 9.9 | 10.0 | 13 Apr 2026 | 8 Jul 2026 |
| Flourishglobal PeptideCASE #VI-2026-0630 | A | 3 | 10.0 | 9.9 | 10.0 | 11 May 2026 | 16 Jun 2026 |
| Shanghai Sigma AudleyCASE #VI-2026-0505 | A | 3 | 10.0 | 9.9 | 10.0 | 27 Dec 2025 | 13 Mar 2026 |
| Hybio PharmaceuticalCASE #VI-2026-0065 | A | 3 | 10.0 | 9.9 | 10.0 | 23 Apr 2026 | 18 Jul 2026 |
| Shanghai ERP BiotechnologyCASE #VI-2026-0936 | A | 2 | 10.0 | 10.0 | 10.0 | 23 Mar 2026 | 6 May 2026 |
| Kerui PeptidesCASE #VI-2026-0626 | A | 2 | 10.0 | 10.0 | 10.0 | 3 Jun 2026 | 12 Jul 2026 |
| PolyPeptide GroupCASE #VI-2026-0143 | A | 2 | 10.0 | 10.0 | 10.0 | 3 Mar 2026 | 2 May 2026 |
| SinoPepCASE #VI-2026-0387 | A | 2 | 10.0 | 10.0 | 10.0 | 28 Feb 2026 | 15 Aug 2026 |
| HomopeptideCASE #VI-2026-0760 | A | 4 | 9.9 | 9.9 | 10.0 | 24 May 2026 | 24 May 2026 |
| JEEP PeptidesCASE #VI-2026-0457 | A | 4 | 9.9 | 9.9 | 10.0 | 7 Feb 2026 | 26 May 2026 |
| Chinese Peptide CompanyCASE #VI-2026-0184 | A | 4 | 9.9 | 9.9 | 10.0 | 17 Nov 2025 | 8 Jul 2026 |
| AsymchemCASE #VI-2026-0091 | A | 4 | 9.9 | 9.9 | 10.0 | 18 May 2026 | 8 Jul 2026 |
| Hubei JianxiangCASE #VI-2026-0048 | A | 3 | 9.9 | 9.9 | 10.0 | 15 Dec 2025 | 3 Jun 2026 |
| Sangon BioCASE #VI-2026-0671 | A | 2 | 9.9 | 9.9 | 9.9 | 26 Nov 2025 | 7 Jun 2026 |
| Shanghai Wibson BiotechnologyCASE #VI-2026-0379 | A | 2 | 9.9 | 9.9 | 10.0 | 18 Feb 2026 | 18 Jun 2026 |
| GenScript PeptidesCASE #VI-2026-0860 | A | 2 | 9.9 | 9.9 | 10.0 | 25 Apr 2026 | 19 May 2026 |
| Sigma-AldrichCASE #VI-2026-0829 | A | 2 | 9.9 | 9.9 | 10.0 | 20 Jun 2026 | 16 Aug 2026 |
| AmbioPharmCASE #VI-2026-0177 | A | 2 | 9.9 | 9.9 | 10.0 | 26 Apr 2026 | 26 May 2026 |
| Haikou Mingheng TechnologyCASE #VI-2026-0250 | X | 1 | 9.0 | 9.0 | 9.0 | 27 Feb 2025 | 27 Feb 2025 |
| Nantong Guangyuan Chemical GYCCASE #VI-2026-0284 | A | 3 | 8.7 | 7.9 | 9.7 | 21 May 2026 | 21 May 2026 |
| Glbiochem (Shanghai)CASE #VI-2026-0704 | A | 7 | 8.5 | 7.0 | 10.0 | 21 May 2026 | 21 May 2026 |
| Wuhan Wansheng Bio (WWB)CASE #VI-2026-0594 | A | 4 | 8.5 | 7.2 | 9.4 | 23 May 2026 | 23 May 2026 |
| Shanghai Sigma Audley SSACASE #VI-2026-0486 | A | 8 | 8.1 | 7.0 | 9.7 | 24 May 2026 | 24 May 2026 |
| Qingdao Sigma Chemical QSCCASE #VI-2026-0538 | A | 4 | 8.1 | 6.7 | 9.2 | 24 May 2026 | 24 May 2026 |
| Skye PeptidesCASE #VI-2026-0451 | X | 6 | 8.0 | 5.7 | 9.7 | 20 Jun 2025 | 23 May 2026 |
| Shandong Shengyuan Peptide TechnologyCASE #VI-2026-0634 | X | 1 | 7.6 | 7.6 | 7.6 | 16 Mar 2025 | 16 Mar 2025 |
| Quenna PMQCASE #VI-2026-0415 | X | 1 | 7.6 | 7.6 | 7.6 | 24 Apr 2025 | 24 Apr 2025 |
| Amino LairCASE #VI-2026-0413 | X | 1 | 7.1 | 7.1 | 7.1 | 2 Apr 2025 | 2 Apr 2025 |
| HazelCASE #VI-2026-0392 | X | 1 | 7.1 | 7.1 | 7.1 | 13 Feb 2025 | 13 Feb 2025 |
| YB PeptideCASE #VI-2026-0813 | X | 1 | 6.9 | 6.9 | 6.9 | 16 Mar 2025 | 16 Mar 2025 |
| Zztai PeptideCASE #VI-2026-0192 | C | 3 | 5.7 | 5.1 | 6.5 | 13 Feb 2025 | 21 May 2026 |
| SRY LabsCASE #VI-2026-0657 | X | 6 | 5.2 | 3.4 | 6.7 | 24 Apr 2025 | 24 May 2026 |
| TydesCASE #VI-2026-0493 | X | 4 | 4.9 | 2.8 | 7.0 | 11 Jun 2025 | 19 Jan 2026 |
| Limitless Life NootropicsCASE #VI-2026-0980 | X | 1 | 4.8 | 4.8 | 4.8 | 20 Jun 2025 | 20 Jun 2025 |
| Wuhan Newtop BiotechCASE #VI-2026-0676 | X | 1 | 1.7 | 1.7 | 1.7 | 24 Apr 2025 | 24 Apr 2025 |
| PRIVATECASE #VI-2026-0635 | X | 1 | 0.0 | 0.0 | 0.0 | 3 Jul 2025 | 3 Jul 2025 |
Open any subject to view the batch-level evidence for TrenMix 200 alone.